CRF Health’s TrialMax eCOA Solution Selected for Landmark Pain Outcomes Study

April 23, 2018

Applied Clinical Trials

CRF Health announced that its TrialMax Touch and TrialMax Slate solutions have been selected by a Global Category Japanese Pharmaceutical company for a pain outcomes study. The Phase III trial will involve 800 screened and 320 randomized subjects across 40 sites in the US.

Read the full release here.

Related Content:

News